Dev-Res-Prog-001

胶质瘤孢子发育研究计划(DRP)的目标是确定创新的试点 具有翻译潜力的胶质瘤研究项目。DRP利用征集和审查程序 选择有功绩的试点项目进行资助。征集过程充分利用了已建立的、广泛的 Dana-Farber/哈佛癌症中心(DF/HCC)通信基础设施广泛传播年度 征求建议书(RFP)。审查过程利用了一个经验丰富的DF/肝细胞癌胶质瘤科学家小组。 DRP为具有最终翻译潜力的创新项目提供有限期限的资金， 可以与现有的孢子项目和核心协同工作。DF/HCC机构从这笔资金中匹配DRP 孢子，以扩大DRP获奖者的池。DRP应用程序将根据其作为试点或 协作研究将产生可行性数据，并使其最终潜力成为完整的项目 在未来几年的孢子计划中。DRP采用监控流程来衡量进度和 DRP项目的结果，包括可能将成功的DRP奖项提升到完整项目。这个 通过明确建立的衡量标准和DRP奖的监督，对计划进行密切监控 委员会审议阶段。DRP获奖者必须提交一年两次的进度报告。

The objective of the Glioma SPORE Developmental Research Program (DRP) is to identify innovative pilot research projects in glioma that have translational potential. The DRP utilizes a solicitation and review process to select meritorious pilot projects for funding. The solicitation process capitalizes on an established, extensive Dana-Farber/Harvard Cancer Center (DF/HCC) communications infrastructure to widely disseminate an annual Request for Proposals (RFP). The review process utilizes an experienced panel of DF/HCC glioma scientists. The DRP provides limited-duration funding for innovative projects that have ultimate translational potential and could synergize with existing SPORE projects and cores. DF/HCC institutions match DRP funding from this SPORE to expand the pool of DRP awardees. The DRP applications are judged for their potential as pilot or collaborative studies that will generate feasibility data and for their ultimate potential to emerge as full projects in future years of the SPORE program. The DRP employs a monitoring process to measure progress and outcomes of DRP projects including the possible elevation of successful DRP awards to full projects. The program is closely monitored through clearly established metrics and oversight by the DRP Awards Committee. DRP awardees are required to present biannual progress reports.